Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Community-level Economic Distress, Race, and Risk of Adverse Outcomes Following Heart Failure Hospitalization among Medicare Beneficiaries.

Circulation

Mentias A, Desai MY, Vaughan-Sarrazin MS, Rao S, Morris AA, Hall JL, Menon V, Hockenberry J, Sims M, Fonarow GC, Girotra S, Pandey A.
PMID: 34743555
Circulation. 2021 Nov 08; doi: 10.1161/CIRCULATIONAHA.121.057756. Epub 2021 Nov 08.

No abstract available.

Cite
Mentias A, Desai MY, Vaughan-Sarrazin MS, et al. Community-level Economic Distress, Race, and Risk of Adverse Outcomes Following Heart Failure Hospitalization among Medicare Beneficiaries. Circulation. 2021;doi: 10.1161/CIRCULATIONAHA.121.057756.
Mentias, A., Desai, M. Y., Vaughan-Sarrazin, M. S., Rao, S., Morris, A. A., Hall, J. L., Menon, V., Hockenberry, J., Sims, M., Fonarow, G. C., Girotra, S., & Pandey, A. (2021). Community-level Economic Distress, Race, and Risk of Adverse Outcomes Following Heart Failure Hospitalization among Medicare Beneficiaries. Circulation, . https://doi.org/10.1161/CIRCULATIONAHA.121.057756
Mentias, Amgad, et al. "Community-level Economic Distress, Race, and Risk of Adverse Outcomes Following Heart Failure Hospitalization among Medicare Beneficiaries." Circulation vol. (2021). doi: https://doi.org/10.1161/CIRCULATIONAHA.121.057756
Mentias A, Desai MY, Vaughan-Sarrazin MS, Rao S, Morris AA, Hall JL, Menon V, Hockenberry J, Sims M, Fonarow GC, Girotra S, Pandey A. Community-level Economic Distress, Race, and Risk of Adverse Outcomes Following Heart Failure Hospitalization among Medicare Beneficiaries. Circulation. 2021 Nov 08; doi: 10.1161/CIRCULATIONAHA.121.057756. Epub 2021 Nov 08. PMID: 34743555.
Copy Download .nbib Format: NLM
Symptom Assessment During Childhood Cancer Treatment.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses

Hockenberry M, Landier W.
PMID: 31307319
J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):242-243. doi: 10.1177/1043454219852611.

No abstract available.

Cite
Hockenberry M, Landier W. Symptom Assessment During Childhood Cancer Treatment. J Pediatr Oncol Nurs. 2019;36(4):242-243doi: 10.1177/1043454219852611.
Hockenberry, M., & Landier, W. (2019). Symptom Assessment During Childhood Cancer Treatment. Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses, 36(4), 242-243. https://doi.org/10.1177/1043454219852611
Hockenberry, Marilyn, and Landier, Wendy. "Symptom Assessment During Childhood Cancer Treatment." Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses vol. 36,4 (2019): 242-243. doi: https://doi.org/10.1177/1043454219852611
Hockenberry M, Landier W. Symptom Assessment During Childhood Cancer Treatment. J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):242-243. doi: 10.1177/1043454219852611. PMID: 31307319; PMCID: PMC7197221.
Copy Download .nbib Format: NLM
A Participatory Integrated Health Promotion and Protection Worksite Intervention: A Cluster Randomized Controlled Trial.

Topics in clinical nutrition

Snetselaar L, Ahrens L, Johnston K, Smith K, Hollinger D, Hockenberry J.
PMID: 32565613
Top Clin Nutr. 2016 Mar;31(1):36-46. doi: 10.1097/tin.0000000000000056.

Our objective was to describe and evaluate an innovative approach to combining worksite wellness and ergonomics, with an emphasis on retention and absenteeism during the intervention. The study enrolled 280 employee participants in a 3-year cluster randomized, controlled trial...

Cite
Snetselaar L, Ahrens L, Johnston K, et al. A Participatory Integrated Health Promotion and Protection Worksite Intervention: A Cluster Randomized Controlled Trial. Top Clin Nutr. 2016;31(1):36-46doi: 10.1097/tin.0000000000000056.
Snetselaar, L., Ahrens, L., Johnston, K., Smith, K., Hollinger, D., & Hockenberry, J. (2016). A Participatory Integrated Health Promotion and Protection Worksite Intervention: A Cluster Randomized Controlled Trial. Topics in clinical nutrition, 31(1), 36-46. https://doi.org/10.1097/tin.0000000000000056
Snetselaar, Linda, et al. "A Participatory Integrated Health Promotion and Protection Worksite Intervention: A Cluster Randomized Controlled Trial." Topics in clinical nutrition vol. 31,1 (2016): 36-46. doi: https://doi.org/10.1097/tin.0000000000000056
Snetselaar L, Ahrens L, Johnston K, Smith K, Hollinger D, Hockenberry J. A Participatory Integrated Health Promotion and Protection Worksite Intervention: A Cluster Randomized Controlled Trial. Top Clin Nutr. 2016 Mar;31(1):36-46. doi: 10.1097/tin.0000000000000056. PMID: 32565613; PMCID: PMC7304740.
Copy Download .nbib Format: NLM
Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries.

Circulation

Mentias A, Desai MY, Vaughan-Sarrazin MS, Rao S, Morris AA, Hall JL, Menon V, Hockenberry J, Sims M, Fonarow GC, Girotra S, Pandey A.
PMID: 34743555
Circulation. 2022 Jan 11;145(2):110-121. doi: 10.1161/CIRCULATIONAHA.121.057756. Epub 2021 Nov 08.

BACKGROUND: Socioeconomic disadvantage is a strong determinant of adverse outcomes in patients with heart failure. However, the contribution of community-level economic distress to adverse outcomes in heart failure may differ across races and ethnicities.METHODS: Patients of self-reported Black, White,...

Cite
Mentias A, Desai MY, Vaughan-Sarrazin MS, et al. Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries. Circulation. 2021;145(2):110-121doi: 10.1161/CIRCULATIONAHA.121.057756.
Mentias, A., Desai, M. Y., Vaughan-Sarrazin, M. S., Rao, S., Morris, A. A., Hall, J. L., Menon, V., Hockenberry, J., Sims, M., Fonarow, G. C., Girotra, S., & Pandey, A. (2022). Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries. Circulation, 145(2), 110-121. https://doi.org/10.1161/CIRCULATIONAHA.121.057756
Mentias, Amgad, et al. "Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries." Circulation vol. 145,2 (2022): 110-121. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.057756
Mentias A, Desai MY, Vaughan-Sarrazin MS, Rao S, Morris AA, Hall JL, Menon V, Hockenberry J, Sims M, Fonarow GC, Girotra S, Pandey A. Community-Level Economic Distress, Race, and Risk of Adverse Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries. Circulation. 2022 Jan 11;145(2):110-121. doi: 10.1161/CIRCULATIONAHA.121.057756. Epub 2021 Nov 08. PMID: 34743555.
Copy Download .nbib Format: NLM
BCL-2 suppresses ceramide-induced cell killing.

Cell death and differentiation

Karasavvas N, Erukulla RK, Bittman R, Lockshin R, Hockenbery D, Zakeri Z.
PMID: 17180067
Cell Death Differ. 1996 Jan;3(1):149-51.

No abstract available.

Cite
Karasavvas N, Erukulla RK, Bittman R, et al. BCL-2 suppresses ceramide-induced cell killing. Cell Death Differ. 1996;3(1):149-51
Karasavvas, N., Erukulla, R. K., Bittman, R., Lockshin, R., Hockenbery, D., & Zakeri, Z. (1996). BCL-2 suppresses ceramide-induced cell killing. Cell death and differentiation, 3(1), 149-51.
Karasavvas, N, et al. "BCL-2 suppresses ceramide-induced cell killing." Cell death and differentiation vol. 3,1 (1996): 149-51.
Karasavvas N, Erukulla RK, Bittman R, Lockshin R, Hockenbery D, Zakeri Z. BCL-2 suppresses ceramide-induced cell killing. Cell Death Differ. 1996 Jan;3(1):149-51. PMID: 17180067.
Copy Download .nbib Format: NLM
Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study.

Journal of pain management

Jacob E, Hockenberry M, Mueller BU, Coates TD, Zeltzer L.
PMID: 20104257
J Pain Manag. 2008;2(1):179-190.

Morphine given by Patient Controlled Analgesia (PCA) is widely used in hospital settings to manage severe pain during acute painful episodes. Wide variations in prescription patterns occur and some patients are often self-administering sub- or low- therapeutic doses. In...

Cite
Jacob E, Hockenberry M, Mueller BU, et al. Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study. J Pain Manag. 2008;2(1):179-190
Jacob, E., Hockenberry, M., Mueller, B. U., Coates, T. D., & Zeltzer, L. (2008). Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study. Journal of pain management, 2(1), 179-190.
Jacob, Eufemia, et al. "Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study." Journal of pain management vol. 2,1 (2008): 179-190.
Jacob E, Hockenberry M, Mueller BU, Coates TD, Zeltzer L. Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study. J Pain Manag. 2008;2(1):179-190. PMID: 20104257; PMCID: PMC2810969.
Copy Download .nbib Format: NLM
Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study.

Journal of pain management

Jacob E, Hockenberry M, Mueller BU.
PMID: 19649172
J Pain Manag. 2008 Jan 01;1(2):173-178.

The use of hydromorphone is increasing but little is known about its effects during painful episodes in adolescents with sickle cell disease. This pilot study examined the intensity, location, and quality of pain and evaluated the amount of relief...

Cite
Jacob E, Hockenberry M, Mueller BU. Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study. J Pain Manag. 2008;1(2):173-178
Jacob, E., Hockenberry, M., & Mueller, B. U. (2008). Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study. Journal of pain management, 1(2), 173-178.
Jacob, Eufemia, et al. "Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study." Journal of pain management vol. 1,2 (2008): 173-178.
Jacob E, Hockenberry M, Mueller BU. Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study. J Pain Manag. 2008 Jan 01;1(2):173-178. PMID: 19649172; PMCID: PMC2718784.
Copy Download .nbib Format: NLM
An electron beam ion trap and source for re-acceleration of rare-isotope ion beams at TRIUMF.

The Review of scientific instruments

Blessenohl MA, Dobrodey S, Warnecke C, Rosner MK, Graham L, Paul S, Baumann TM, Hockenbery Z, Hubele R, Pfeifer T, Ames F, Dilling J, Crespo López-Urrutia JR.
PMID: 29864823
Rev Sci Instrum. 2018 May;89(5):052401. doi: 10.1063/1.5021045.

Electron beam driven ionization can produce highly charged ions (HCIs) in a few well-defined charge states. Ideal conditions for this are maximally focused electron beams and an extremely clean vacuum environment. A cryogenic electron beam ion trap fulfills these...

Cite
Blessenohl MA, Dobrodey S, Warnecke C, et al. An electron beam ion trap and source for re-acceleration of rare-isotope ion beams at TRIUMF. Rev Sci Instrum. 2018;89(5):052401doi: 10.1063/1.5021045.
Blessenohl, M. A., Dobrodey, S., Warnecke, C., Rosner, M. K., Graham, L., Paul, S., Baumann, T. M., Hockenbery, Z., Hubele, R., Pfeifer, T., Ames, F., Dilling, J., & Crespo López-Urrutia, J. R. (2018). An electron beam ion trap and source for re-acceleration of rare-isotope ion beams at TRIUMF. The Review of scientific instruments, 89(5), 052401. https://doi.org/10.1063/1.5021045
Blessenohl, M A, et al. "An electron beam ion trap and source for re-acceleration of rare-isotope ion beams at TRIUMF." The Review of scientific instruments vol. 89,5 (2018): 052401. doi: https://doi.org/10.1063/1.5021045
Blessenohl MA, Dobrodey S, Warnecke C, Rosner MK, Graham L, Paul S, Baumann TM, Hockenbery Z, Hubele R, Pfeifer T, Ames F, Dilling J, Crespo López-Urrutia JR. An electron beam ion trap and source for re-acceleration of rare-isotope ion beams at TRIUMF. Rev Sci Instrum. 2018 May;89(5):052401. doi: 10.1063/1.5021045. PMID: 29864823.
Copy Download .nbib Format: NLM
Role of Insulin in Neurotrauma and Neurodegeneration: A Review.

Frontiers in neuroscience

Shaughness M, Acs D, Brabazon F, Hockenbury N, Byrnes KR.
PMID: 33100956
Front Neurosci. 2020 Sep 23;14:547175. doi: 10.3389/fnins.2020.547175. eCollection 2020.

Insulin is a hormone typically associated with pancreatic release and blood sugar regulation. The brain was long thought to be "insulin-independent," but research has shown that insulin receptors (IR) are expressed on neurons, microglia and astrocytes, among other cells....

Cite
Shaughness M, Acs D, Brabazon F, et al. Role of Insulin in Neurotrauma and Neurodegeneration: A Review. Front Neurosci. 2020;14:547175doi: 10.3389/fnins.2020.547175.
Shaughness, M., Acs, D., Brabazon, F., Hockenbury, N., & Byrnes, K. R. (2020). Role of Insulin in Neurotrauma and Neurodegeneration: A Review. Frontiers in neuroscience, 14547175. https://doi.org/10.3389/fnins.2020.547175
Shaughness, Michael, et al. "Role of Insulin in Neurotrauma and Neurodegeneration: A Review." Frontiers in neuroscience vol. 14 (2020): 547175. doi: https://doi.org/10.3389/fnins.2020.547175
Shaughness M, Acs D, Brabazon F, Hockenbury N, Byrnes KR. Role of Insulin in Neurotrauma and Neurodegeneration: A Review. Front Neurosci. 2020 Sep 23;14:547175. doi: 10.3389/fnins.2020.547175. eCollection 2020. PMID: 33100956; PMCID: PMC7546823.
Copy Download .nbib Format: NLM
Incidence and impact of acute urinary retention after robot-assisted radical prostatectomy.

Prostate international

Shahait M, Hockenberry M, Suzy NA, Kim J, McWilliams K, Lee DI.
PMID: 33102393
Prostate Int. 2020 Sep;8(3):121-124. doi: 10.1016/j.prnil.2020.03.001. Epub 2020 Mar 18.

OBJECTIVE: To explore the incidence of and potential risk factors for acute urine retention (AUR) after robot-assisted radical prostatectomy (RARP) and its effect on early urine continence.METHODS: A retrospective analysis of patients who underwent RARP by a single surgeon...

Cite
Shahait M, Hockenberry M, Suzy NA, et al. Incidence and impact of acute urinary retention after robot-assisted radical prostatectomy. Prostate Int. 2020;8(3):121-124doi: 10.1016/j.prnil.2020.03.001.
Shahait, M., Hockenberry, M., Suzy, N. A., Kim, J., McWilliams, K., & Lee, D. I. (2020). Incidence and impact of acute urinary retention after robot-assisted radical prostatectomy. Prostate international, 8(3), 121-124. https://doi.org/10.1016/j.prnil.2020.03.001
Shahait, Mohammed, et al. "Incidence and impact of acute urinary retention after robot-assisted radical prostatectomy." Prostate international vol. 8,3 (2020): 121-124. doi: https://doi.org/10.1016/j.prnil.2020.03.001
Shahait M, Hockenberry M, Suzy NA, Kim J, McWilliams K, Lee DI. Incidence and impact of acute urinary retention after robot-assisted radical prostatectomy. Prostate Int. 2020 Sep;8(3):121-124. doi: 10.1016/j.prnil.2020.03.001. Epub 2020 Mar 18. PMID: 33102393; PMCID: PMC7557181.
Copy Download .nbib Format: NLM
Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer.

Cancers

Tarragó-Celada J, Foguet C, Tarrado-Castellarnau M, Marin S, Hernández-Alias X, Perarnau J, Morrish F, Hockenbery D, Gomis RR, Ruppin E, Yuneva M, Atauri P, Cascante M.
PMID: 33498690
Cancers (Basel). 2021 Jan 23;13(3). doi: 10.3390/cancers13030425.

With most cancer-related deaths resulting from metastasis, the development of new therapeutic approaches against metastatic colorectal cancer (mCRC) is essential to increasing patient survival. The metabolic adaptations that support mCRC remain undefined and their elucidation is crucial to identify...

Cite
Tarragó-Celada J, Foguet C, Tarrado-Castellarnau M, et al. Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer. Cancers (Basel). 2021;13(3)doi: 10.3390/cancers13030425.
Tarragó-Celada, J., Foguet, C., Tarrado-Castellarnau, M., Marin, S., Hernández-Alias, X., Perarnau, J., Morrish, F., Hockenbery, D., Gomis, R. R., Ruppin, E., Yuneva, M., Atauri, P., & Cascante, M. (2021). Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer. Cancers, 13(3), . https://doi.org/10.3390/cancers13030425
Tarragó-Celada, Josep, et al. "Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer." Cancers vol. 13,3 (2021). doi: https://doi.org/10.3390/cancers13030425
Tarragó-Celada J, Foguet C, Tarrado-Castellarnau M, Marin S, Hernández-Alias X, Perarnau J, Morrish F, Hockenbery D, Gomis RR, Ruppin E, Yuneva M, Atauri P, Cascante M. Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer. Cancers (Basel). 2021 Jan 23;13(3). doi: 10.3390/cancers13030425. PMID: 33498690; PMCID: PMC7866204.
Copy Download .nbib Format: NLM
Vasectomy reversal: decision making and technical innovations.

Translational andrology and urology

Kirby EW, Hockenberry M, Lipshultz LI.
PMID: 28904908
Transl Androl Urol. 2017 Aug;6(4):753-760. doi: 10.21037/tau.2017.07.22.

Vasectomy is the method of contraception chosen by more than 500,000 American men annually, and by upwards of 8% of married couples worldwide. However, following the procedure, nearly 20% of men express the desire for children in the future,...

Cite
Kirby EW, Hockenberry M, Lipshultz LI. Vasectomy reversal: decision making and technical innovations. Transl Androl Urol. 2017;6(4):753-760doi: 10.21037/tau.2017.07.22.
Kirby, E. W., Hockenberry, M., & Lipshultz, L. I. (2017). Vasectomy reversal: decision making and technical innovations. Translational andrology and urology, 6(4), 753-760. https://doi.org/10.21037/tau.2017.07.22
Kirby, E Will, et al. "Vasectomy reversal: decision making and technical innovations." Translational andrology and urology vol. 6,4 (2017): 753-760. doi: https://doi.org/10.21037/tau.2017.07.22
Kirby EW, Hockenberry M, Lipshultz LI. Vasectomy reversal: decision making and technical innovations. Transl Androl Urol. 2017 Aug;6(4):753-760. doi: 10.21037/tau.2017.07.22. PMID: 28904908; PMCID: PMC5583052.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries